Clinically-based determination of safe D
β
Daniele Lilleri; Fausto Baldanti; Marta Gatti; Francesca Rovida; Luca Dossena; S
π
Article
π
2004
π
John Wiley and Sons
π
English
β 101 KB
## Abstract Transplantation Centers using human cytomegalovirus (HCMV) antigenemiaβbased preemptive therapy will need to replace in the near future the antigenemia assay with a more standardized and automatable assay, such as a molecular assay quantifying HCMV DNA in blood (DNAemia). Thus, in view